AnuragSinghMD

PubMed

• Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review.
  Muhammad Fareed Khalid, Muhammad Kashif Amin, Ali H Mushtaq, Atif Butt, Iqra Anwar, Moazzam Shahzad, Mohammad Ammad-Ud-Din, Usman Ilyas, Sibgha Gull Chaudhary, Naushee...> ;Hematology/oncology and Stem Cell Therapy. 2024 Mar 22
• Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.
  Maze, D., Arcasoy, M., Henrie, R., Cerquozzi, S., Kamble, R., Al-Hadidi, S., Yacoub, A., Singh, A., Elsawy, M., Sirhan, S., Smith, E., Marcoux, C., Viswabandya, A., Da...> ;Bone Marrow Transplantation. 2024 Feb 1
• 1 citations
  Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation.
  Amin, M., DeJarnette, S., Li, K., Mushtaq, M., Shahzad, M., Lutfi, F., Al-Ramahi, J., Ahmed, N., Bansal, R., Abdelhakim, H., Shune, L., Abdallah, A., Abhyankar, S., Mc...> ;Leukemia & Lymphoma. 2024 Apr 1
• Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.
  Amin, M., Mushtaq, M., Joe S Al-Ramahi, Moazzam Shahzad, Andrea Nguyen, Kevin Li, Muhammad Kashif Amin, Nausheen Ahmed, Forat Lutfi, Shaun DeJarnette, Sibgha Gull Chau...> ;Bone Marrow Transplantation. 2024 Jan 1
• Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.
  Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, Anurag K Singh, Mahmoud Elsawy, Shireen Sirhan, Elliot ...> ;Bone Marrow Transplantation. 2024 Feb 1
• 3 citations
  Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute...
  Moazzam Shahzad, Ali Hussain, Ezza Tariq, Iqra Anwar, Muhammad S Faisal, Leena Syed, Alvina Karam, Sibgha Gull Chaudhary, Nausheen Ahmed, Rajat Bansal, Sharad Khurana,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Mar 1
• Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
  Moazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, Ali Hassan Mushtaq, Iqra Anwar, Nausheen Ahmed, Rajat Bansal, Forat Lutfi, Ramesh Balusu, Haitham Abdelhakim, Abdul...> ;Leukemia & Lymphoma. 2023 Feb 1
• 11 citations
  Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis.
  Moazzam Shahzad, Ezza Tariq, Sibgha Gull Chaudhary, Iqra Anwar, Qamar Iqbal, Huda Fatima, Haitham Abdelhakim, Nausheen Ahmed, Ramesh Balusu, Peiman Hematti, Anurag K S...> ;Leukemia & Lymphoma. 2022 Dec 1
• 1 citations
  Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
  Muhammad Umair Mushtaq, Moazzam Shahzad, Amna Y Shah, Sibgha Gull Chaudhary, Muhammad U Zafar, Iqra Anwar, Karun Neupane, Ayesha Khalid, Nausheen Ahmed, Rajat Bansal, ...> ;Frontiers in Immunology. 2022 Jan 1
• 5 citations
  Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis.
  Muhammad Umair Mushtaq, Moazzam Shahzad, Ezza Tariq, Qamar Iqbal, Sibgha Gull Chaudhary, Muhammad U Zafar, Iqra Anwar, Nausheen Ahmed, Rajat Bansal, Anurag K Singh, Su...> ;Frontiers in Oncology. 2022 Jan 1
• 4 citations
  Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment
  Alain Mina, Leyla Shune, Haitham Abdelhakim, Tara L. Lin, Sid Ganguly, Andrea Baran, Anurag K. Singh, Sunil Abhyankar, Joseph P. McGuirk, Dennis Allin, Omar S. Aljitawi> ;Annals of Hematology. 2019 Feb 1
• 1 citations
  Evaluation of cytomegalovirus reactivation and tolerability in seropositive umbilical cord transplant patients after implementation of an intensive prevention strategy
  Matthew Rinehart, Erica Hochard, Michelle Rockey, Sunil Abhyankar, Siddhartha Ganguly, Tara L. Lin, Joseph McGuirk, Leyla Shune, Anurag Singh, Omar S. Aljitawi> ;Hematology/oncology and Stem Cell Therapy. 2016 Sep 1
• Join now to see all

Abstracts/Posters

• Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
  Anurag K. Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  Anurag K. Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• In-Hospital Morbidity and Mortality Among Acute Myeloid Leukemia Patients Admitted for Hematopoeitic Stem Cell Transplants between 2002-2014
  Anurag K. Singh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019